AnPac Bio-Medical Science Co., Ltd. (ANPC) Research

AnPac Bio-Medical Science Co., Ltd. is a biotechnology firm that specializes in developing and commercializing tests designed for the early detection and screening of various cancer types. These diagnostic tools leverage the company's unique Cancer Differentiation Analysis (CDA) technology and associated devices. AnPac Bio primarily provides these solutions to corporate entities and life insurance companies across the People's Republic of China. Additionally, the company extends its offerings to include comprehensive physical examination package services. AnPac Bio was established in 2010 and maintains its main operational base in Lishui, China.

Market snapshot

Symbol
ANPC
Price
$4.30
Day change
-3.15%
Market cap
$182.6M
P/E ratio
-0.54x
52-week range
2.6-11.99
Sector
Healthcare
Industry
Biotechnology

Peer companies

  • Allakos Inc. (ALLK)
  • Angion Biomedica Corp. (ANGN)
  • Elevation Oncology, Inc. (ELEV)
  • Freeline Therapeutics Holdings plc (FRLN)
  • Gemini Therapeutics, Inc. (GMTX)
  • Liminal BioSciences Inc. (LMNL)
  • LakeShore Biopharma Co., Ltd (LSB)
  • Marinus Pharmaceuticals, Inc. (MRNS)

Recent insider activity

  • Xu Haohan — trade (0 shares) on 2024-01-01
  • Xu Haohan — trade (0 shares) on 2024-01-01

Open AnPac Bio-Medical Science Co., Ltd. (ANPC) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.